BioSpace News Archive

CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions, announced that it has appointed Carrie Ann Cook to the position of Senior Vice-President/Global Head of Business Development, effective June 8 th . With more than 20

Cobra Biologics (Cobra), part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals, today announced it has signed a supply agreement with AstraZeneca UK Ltd. (“AstraZeneca”) to provide GMP manufacture of th

The Muscular Dystrophy Association announced its annual summer camp, which services more 3,000 children ages 8 to 17 living with neuromuscular diseases, will be held virtually in response to the COVID-19 pandemic.

Real-world data, coupled with Alira Health’s lifecycle approach, offers clients deeper insights and patient-centric approaches to drive transformation across healthcare.

- Atomic layer deposition (ALD) GeAsSeTe Ovonic Threshold Switch (OTS) device advances applications of 3D Non-volatile memory (NVM) - Enables new innovations in Neuromorphic Computing, AI, Gaming and Data Centers

GA Global Partners today announced that it will conduct an online public auction of the assets of Second Sight Medical Products, Inc. on June 25, 2020.

Rochester Regional Health announced the launch of an integrated specialty pharmacy service to further enhance care for its patients with chronic and complex conditions.

bioAffinity Technologies , a privately held biomedical company, today named its research laboratories in memoriam of Harvey Sandler, a businessman who used his considerable success to support research that advances diagnostic tests and targeted treatments for cancer. “It was due to Harvey’s initial investment that bioAffin

WEG232 is a topical treatment with specific substance P-receptor inhibitor for Erlotinib-induced facial dermatitis and hair loss in cancer patients [16-June-2020] NEW YORK , June 16, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) a biopharmaceutical company, today announced that it has expanded its sponsored research agreement with the George Washington U

Intabio, Inc., a developer of analytical solutions that provide profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today announces commercial availability of the Blaze System. Blaze addresses a critical bottleneck for biopharmaceutical developers by identifying unwanted structural modificat